Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …

Nowadays, non-biological treatments remain valuable approaches among the therapeutic
armamentarium of inflammatory bowel disease (IBD). Mesalamine is the core treatment of …

Objective To evaluate the risk of common infections in individuals with inflammatory bowel
disease (IBD)[ulcerative colitis and Crohn's disease] compared with matched controls in a …

The use of corticosteroids to treat patients with inflammatory bowel disease [IBD] has been
the bedrock of IBD therapeutics since the pioneering work of Truelove and Witts in the UK in …

Abstract Background and Aims Recent treatment guidelines for ulcerative colitis [UC] do not
recommend long-term corticosteroid [CS] use. The present study aimed to capture the …

Background Corticosteroids are central to inducing remission in inflammatory bowel disease
(IBD) but are ineffective maintenance agents. Aim To benchmark steroid usage in British …

Summary Background 5‐aminosalicylates (5‐ASA) are widely used in Crohn's disease (CD)
despite guidelines advising otherwise. We aimed to assess in nationwide study the …

Background Patients with IBD are at risk of excess corticosteroids. Aims To assess steroid
excess in a large IBD cohort and test associations with quality improvement and prescribing …